Skip to main content

1 Result(s)

within Norbert Blesing Remove this filter

and

  1. No Access

    Article

    Bendamustine in combination with thalidomide and dexamethasone is a viable salvage option in myeloma relapsed and/or refractory to bortezomib and lenalidomide

    Treatment options are limited in myeloma relapsed or refractory to both bortezomib and lenalidomide (double-relapsed/refractory multiple myeloma; DRMM). Bendamustine is an antitumour agent that has efficacy in...

    I-Jun Lau, Dean Smith, Robin Aitchison, Norbert Blesing… in Annals of Hematology (2015)